PedAM
Pediatric Disease Annotations & Medicines
| Disease | amyloidosis |
| Symptom | C0018801|heart failure |
| Sentences | 14 |
| PubMedID- 25803181 | The clinician must consider a diagnosis of cardiac amyloidosis in patients with heart failure, a restrictive type of cardiomyopathy with ventricular hypertrophy in the absence of valve abnormalities, or uncontrolled arterial hypertension. |
| PubMedID- 23259134 | She had undergone orthotopic heart transplantation 5 weeks earlier for end-stage heart failure due to primary systemic amyloidosis (amyloid light-chain, al) with severe cardiac involvement with restriction diagnosed only few weeks before. |
| PubMedID- 26493509 | A case of primary gastric amyloidosis with fulminant heart failure. |
| PubMedID- 22949774 | We implanted a continuous-flow total heart replacement device in a 55-year-old man who had severe end-stage heart failure due to amyloidosis and no other options for treatment. |
| PubMedID- 25510353 | Cardiac amyloidosis is a cause of diastolic heart failure in which ejection fraction (ef) remains "normal" despite progression of disease. |
| PubMedID- 23417147 | Cardiac involvement is found in approximately 50% of patients with systemic al amyloidosis, leading to congestive heart failure and death2. |
| PubMedID- 21755769 | Many cases of progressive heart failure due to cardiac amyloidosis remain undiagnosed due to the rarity and lack of suspicion on part of physician. |
| PubMedID- 25374735 | The pathogenesis most frequently involves congestive heart failure due to amyloidosis and cardiac disease in the older myeloma population . |
| PubMedID- 23868674 | Systemic light-chain amyloidosis presenting with rapid progressive heart failure. |
| PubMedID- 21169191 | Cardiac involvement occurs frequently in primary amyloidosis and is associated with heart failure hospitalizations and poor survival. |
| PubMedID- 26224076 | Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. |
| PubMedID- 24298723 | A 64 year old patient with heart failure due to primary cardiac amyloidosis is described. |
| PubMedID- 24200511 | The purpose of this study was to identify predictors of survival to oht in patients with end-stage heart failure due to al amyloidosis and compare post-oht survival of cardiac amyloid patients with survival of other cardiomyopathy patients undergoing oht. |
| PubMedID- 23278526 | Combined heart-liver transplantation (chltx) is the preferred treatment for patients with heart failure due to familial amyloidosis, but information on outcome of patients with leu111met mutation is limited. |
Page: 1